Quick Answer
Akebia Therapeutics, Inc. reported Total Revenue of $236.20 million for fiscal year 2025.
Akebia Therapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $236.20M | +47.5% |
| 2024 | $160.18M | -17.7% |
| 2023 | $194.62M | -33.5% |
| 2022 | $292.48M | +36.9% |
| 2021 | $213.58M | -27.7% |
| 2020 | $295.31M | -11.8% |
| 2019 | $335.00M | +61.3% |
| 2018 | $207.74M | +14.6% |
| 2017 | $181.23M | +11706.3% |
| 2016 | $1.53M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $58.77M | +57.0% | -5.9% |
| June 30, 2025 | $62.47M | +43.1% | +9.0% |
| March 31, 2025 | $57.34M | +75.8% | +53.2% |
| September 30, 2024 | $37.43M | -11.0% | -14.3% |
| June 30, 2024 | $43.65M | -22.6% | +33.9% |
| March 31, 2024 | $32.61M | -18.5% | -22.4% |
| September 30, 2023 | $42.05M | -13.7% | -25.4% |
| June 30, 2023 | $56.38M | -55.4% | +40.9% |
- Akebia Therapeutics, Inc. showed an increase of +47.5% in Total Revenue compared to the prior fiscal year.
- Over the 2016–2025 period, Akebia Therapeutics, Inc.’s total revenue has grown by 15287.4% (from $1.53 million to $236.20 million).
- The most recent figure is from Akebia Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: